MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
30 hedge funds and large institutions have $87.2M invested in MedTech Acquisition Corporation Unit in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 31 → 30 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
14% less capital invested
Capital invested by funds: $102M → $87.2M (-$14.5M)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCL
Bracebridge Capital LLC
Boston,
Massachusetts
|
+$3M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.48M |
| 3 |
HP
Hartree Partners
New York
|
+$872K |
| 4 |
VF
Virtu Financial
New York
|
+$408K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
Diameter Capital Partners
New York
|
-$6.72M |
| 2 |
VI
Vestcor Inc
Fredericton,
New Brunswick, Canada
|
-$2.35M |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
-$2.01M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$1.88M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$1.88M |
MTACU Hedge Fund Activity: Q2 2021 in Review
30 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q2 2021, worth a combined $87.2M — down 14% from $102M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MTACU and 8 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 3 added.
The largest buyer was Bracebridge Capital LLC, opening a new position worth an estimated $3M. The largest seller was Diameter Capital Partners, cutting an estimated $6.72M.
- 30 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q2 2021, down from 31 in Q1 2021.
- Funds reported $87.2M of MedTech Acquisition Corporation Unit stock for Q2 2021, down 14% quarter-over-quarter.
- 8 funds opened new MedTech Acquisition Corporation Unit positions in Q2 2021 and 9 closed out, a net change of -1 holder.
- The largest MedTech Acquisition Corporation Unit buyer in Q2 2021 was Bracebridge Capital LLC, an estimated $3M added.
- The largest MedTech Acquisition Corporation Unit seller in Q2 2021 was Diameter Capital Partners, an estimated $6.72M sold.
Based on aggregated 13F filings for Q2 2021.